Dutch Treat is a modern hybrid-indica strain with an undocumented lineage. According to lore, the strain is widely credited to the Pacific Northwest, where it attained a reputation within the regional cannabis community for its consistent performance. Cultivators can expect a moderate difficulty level when growing the plant in both indoor and outdoor environments, with a flowering phase of approximately 49 days and the potential for a high yield.

The complex organoleptic profile of Dutch Treat is defined by a diverse array of chemical compounds, led by dominant terpinolene followed by myrcene and ocimene. Secondary and tertiary contributions come from caryophyllene, limonene, beta-pinene, humulene, pinene, isopulegol, guaiol, valencene, linalool, bisabolol, alpha-terpinene, gamma-terpinene, caryophyllene-oxide, nerolidol, sabinene, p-cymene, eucalyptol, camphene, and borneol. This intricate chemical structure produces a nuanced sensory experience that reflects the wide variety of terpenes present in the plant profile.

As a THC-dominant variety, Dutch Treat is primarily sought for its ability to induce states described as relaxed, calm, and focused. These effects make the strain a functional option for clinical use cases involving the management of pain, stress, and sleep. The influence of the strain continues to circulate through its genetic legacy, which includes notable offspring such as Blue Treat, Champagne Skies, Dutch Cookies, Dutch Treat x (ASD x Blue Fire), Dutch Treat x Hashplant, Dutch Treat x Northern Lights, Dutchberry, God's Treat, Purple Skunk x Dutch Treat, and Zmäkdaun.